Complete Up To Date Information about Clomicalm Tablets.
NADA Number: 141-120 | |
| Proprietary Name |
Clomicalm® Tablets |
|---|---|
| Sponsor |
Novartis Animal Health US, Inc. |
| Sponsor Address |
3200 Northline Ave, Suite 300 Greensboro, NC 27408 USA |
| Ingredients |
Clomipramine Hydrochloride |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
| Exclusivity |
No active ingredient of the drug has been previously approved. |
|
Dosage Amount, Indications & Limitations |
520.455 Clomipramine tablets. Specifications: Each tablet contains 5, 20, 40, or 80 milligrams of clomipramine hydrochloride. Conditions of use: Dogs Amount: 2 to 4 milligrams of clomipramine hydrochloride per kilogram (0.9 to 1.8 milligrams per pound) of body weight per day, administered as a single daily dose or divided twice daily. Indications: For use as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |